ArticleJournal of the National Cancer Institute2026
Federal housing assistance, cancer care, and overall survival among older adults with prostate cancer.
Article in Journal of the National Cancer Institute, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
backgroundSurvival disparities in prostate cancer are driven in part by social and economic factors, including housing insecurity. Rent subsidies in the form of federal housing assistance are a well-established strategy for alleviating housing insecurity, but their association with prostate cancer care and survival is unknown.
methodsUsing linked federal housing assistance data, SEER cancer registry data, and Medicare claims, we assessed workup and treatment receipt and 2-year survival among individuals aged 66-95 who were diagnosed with prostate cancer in 2007 to 2019. We used logistic and Cox regression models to compare outcomes between individuals receiving housing assistance upon prostate cancer diagnosis and a comparison group without housing assistance, using propensity score matching to balance sociodemographic and clinical characteristics.
resultsThere were 1839 individuals with housing assistance (and 5517 without assistance) included in the workup and treatment analyses and 4451 individuals with housing assistance (and 13 353 without assistance) in the survival models. Receipt of housing assistance was not associated with guideline-concordant workup (62.7% vs. 61.2%, OR = 1.02, 95% CI = 0.97 to 1.07, P = .48) or active treatment (63.7% vs. 62.2%, OR = 1.02, 95% CI = 0.99 to 1.06, P = .22) but was associated with improved overall survival in the 2 years following diagnosis (hazard ratio for mortality: OR = 0.88, 95% CI = 0.81 to 0.96).
conclusionsOlder adults receiving housing assistance at the time of a prostate cancer diagnosis experienced better overall survival than a matched comparison group without housing assistance. Results suggest that expanding access to housing assistance might support greater and more equitable survival in prostate cancer.
Indexed as
Identifiers
42014098What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.